Antineo
Preclinical oncology services, in vitro services and development of immunotherapies.
What they do
- Services
- Preclinical oncology services
- In vitro services
- Development of immunotherapies
- End-point studies
- Continuous monitoring studies
- Resistant cell lines
- Sample characterisation
- 3D bioprinting of tumors
- Ex vivo services
- In vivo services
- PK studies
- Efficacy studies
- Ex vivo immunology assays
- ADCC assays
- ADCP assays
- MTT assays
- IC50 determination
- Synergy assays
- Cell cycle analysis
- Apoptosis analysis
- Multiple colour flow cytometry
- T Cell activation assays
- T Cell proliferation assays
- Mixed Lymphocyte reactions
- xCELLigence analysis
- IncuCyte imaging
- High-throughput sequencing
- RNA-Seq
- Quantitative PCR (qPCR)
- Western Blotting
- Immunoprecipitation (IP)
- 150+ tumour models
- Resistance models
- Custom model development
- 29-marker panels
- Immunophenotyping
- 3D tumor printing
- Humanized models
- Animal facility capacity
Quality & certifications
Antineo is a privately-owned Contract Research Organisation founded in 2015. Source (opens in a new tab)